Nope. There is a big difference between less toxic and protective. Bisantrene was though to be a less cardiotoxic anthracene derivative, but it is actually cardioprotective. The former causes no damage, whereas the latter repairs damage done - very, very different. Antibody drug conjugates are not new to oncology, and they can damage the heart.
General Comments / Chat, page-11311
-
- There are more pages in this discussion • 705 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.50 |
Change
0.035(2.39%) |
Mkt cap ! $258.2M |
Open | High | Low | Value | Volume |
$1.50 | $1.52 | $1.50 | $63.95K | 42.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4063 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.51 | 790 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4063 | 1.500 |
1 | 782 | 1.495 |
1 | 2070 | 1.490 |
1 | 312 | 1.465 |
1 | 2000 | 1.460 |
Price($) | Vol. | No. |
---|---|---|
1.505 | 790 | 2 |
1.510 | 352 | 1 |
1.515 | 353 | 1 |
1.520 | 2366 | 4 |
1.525 | 389 | 1 |
Last trade - 11.33am 04/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |